Introduction
============

Cellular proteins undergo a vast array of dynamic and static modifications to their amino acid backbone, which can dramatically extend and regulate functional output. Some of these modifications, phosphorylation in particular, have been the subject of intensive research, and their regulation and intracellular functions are extensively characterized. In contrast, our understanding of S-palmitoylation (hereafter referred to as palmitoylation), the attachment of palmitate (C16:0) or other long chain fatty acids to cysteine residues, has lagged behind some of its more popular cousins. Indeed, enzymes that catalyze palmitoylation reactions have only recently been identified after landmark studies in yeast, settling a long-running debate as to whether this process was predominantly enzyme mediated or spontaneous ([@bib50]; [@bib72]; [@bib22]; [@bib43]).

Palmitoylation is one of a group of lipid modifications (collectively termed lipidation) that appears on eukaryotic proteins and includes the common N-myristoyl and isoprenyl modifications. N-myristoylation describes the addition of myristic acid (C14:0) to a glycine residue with an exposed NH~2~ group after cleavage of the immediately adjacent initiating methionine ([@bib94]; [@bib68]). This process is predominantly cotranslational, mediated by soluble enzymes, and has a strict consensus sequence (M**G**XXXS/T). N-myristoylation can also occur posttranslationally, notably after caspase-mediated protein cleavage during programmed cell death ([@bib94]). Prenylation is a posttranslational process also catalyzed by soluble enzymes, involving the attachment of farnesyl or geranylgeranyl isoprenoids to a C-terminal cysteine present within a defined consensus sequence ([@bib91]).

Unlike the catalysts of N-myristoylation and prenylation reactions, the enzymes that mediate palmitoylation are polytopic membrane proteins ([@bib22]; [@bib55]), implying that cellular palmitoylation reactions occur at the cytosol--membrane interface. There are ∼23 putative S-palmitoyl transferases in mammals, characterized by the presence of a DHHC (aspartate-histidine-histidine-cysteine) motif within an ∼50 amino acid cysteine-rich domain. The large number of these DHHC proteins coupled with their localization to distinct membrane compartments ([@bib63]) implies that the cellular palmitoylation machinery is a highly regulated and coordinated system.

There is no strict consensus sequence for palmitoylation, however, palmitoylated cysteines do share some common characteristics: (a) they are often adjacent to myristoylation and prenylation sites, (b) the surrounding amino acids tend to be basic or hydrophobic, and (c) they are frequently located in the cytoplasmic regions flanking transmembrane domains (or within transmembrane domains). An elegant combined proteomic and genetic analysis in yeast revealed that some DHHC proteins appear to exhibit a preference for a particular class of substrate, e.g., transmembrane proteins or myristoylated/prenylated proteins ([@bib73]). Similarly, some palmitoylated yeast proteins displayed a marked dependence on a specific DHHC protein (of which seven are expressed in yeast). However, this study also revealed that DHHC proteins can have overlapping substrate specificities, which is consistent with previous studies in mammalian systems showing that specific substrates can be palmitoylated by more than one DHHC protein ([@bib22]; [@bib19]; [@bib20]; [@bib27], [@bib30]; [@bib86]; [@bib77]).

Regulatory effects of palmitoylation
====================================

Palmitoylation often couples with either N-myristoylation or prenylation to regulate membrane interactions of soluble proteins. N-myristoylation or prenylation of proteins in the cell cytosol provides a degree of hydrophobicity, although single lipid modifications are only sufficient for transient membrane interaction ([@bib76]). In contrast, two closely positioned lipid modifications promote stable membrane attachment ([@bib76]). Thus, at the cellular level, single myristoyl or prenyl chains facilitate transient membrane association, which is sufficient to allow access to membrane-bound DHHC proteins; subsequent palmitoylation by DHHC proteins will then promote stable membrane binding by inhibiting membrane dissociation (kinetic trapping; [Fig. 1 A](#fig1){ref-type="fig"}). In this way, palmitoylation is essential for stable membrane association of many proteins, including farnesylated Ras and myristoylated Gα subunits ([@bib31]; [@bib49]; [@bib66]). Several soluble lipidated proteins are modified exclusively by S-palmitoylation, and these proteins may use an intrinsic weak membrane affinity for transient membrane interaction before palmitoylation ([@bib27], [@bib28]).

![**Regulation of membrane binding and trafficking of peripheral proteins by palmitoylation.** (A) Proteins modified with single lipid groups (prenylation or N-myristoylation; green circles) have a weak membrane affinity that allows transient membrane interaction. Palmitoylation by membrane-bound DHHC proteins promotes stable membrane association by kinetic trapping ([@bib76]). Note that some peripheral proteins are exclusively palmitoylated, and these proteins were suggested to interact with membranes before palmitoylation by way of an intrinsic weak membrane affinity ([@bib27], [@bib28]). (B) Palmitoylation of Ras-farnesyl by Golgi-localized DHHC proteins leads to a dramatic increase in membrane affinity by kinetic trapping. This increased membrane residency facilitates entry of palmitoylated Ras (red circles) into transport vesicles that deliver it to the plasma membrane. It is possible that palmitoylation also serves to move Ras into cholesterol-rich domains from which Golgi exit vesicles are formed ([@bib67]). Depalmitoylation of Ras can occur anywhere in the cell, perhaps modulated by Apt1, resulting in membrane release and cytosolic diffusion before repalmitoylation at the Golgi. For simplicity, the figure only depicts depalmitoylation occurring at the plasma membrane. This palmitoylation/depalmitoylation regulation of protein sorting is not specific for Ras proteins and may be a common mechanism underlying the sorting of many peripheral palmitoylated proteins ([@bib40]; [@bib86]; [@bib71]).](JCB_201008160_RGB_Fig1){#fig1}

Therefore, it is clear that a major function of palmitoylation is to mediate stable membrane attachment of soluble proteins. However, the effects of this posttranslational modification are more complex and diverse than that of a simple membrane anchor, and indeed, many transmembrane proteins are also palmitoylated. Analyses of different proteins and systems have revealed that palmitoylation has many distinct effects on modified proteins, regulating protein trafficking, protein stability, membrane microlocalization, and protein--protein interactions ([@bib68],[@bib69]; [@bib26]; [@bib48]; [@bib29]; [@bib61]). Although these effects of palmitoylation appear diverse, they are likely determined by two particular properties of palmitate: hydrophobicity/membrane affinity and preference for ordered cholesterol-rich membrane domains or rafts ([@bib53]; [@bib7]).

A central function of palmitoylation is the regulation of protein sorting ([@bib29]), and it might be predicted that this simple lipid modification would have a very limited repertoire of effects on this process. However, this is not the case, and palmitoylation has been shown to act as a highly versatile sorting signal, which regulates protein trafficking to many distinct intracellular compartments. Several studies have highlighted regulatory effects of palmitoylation on either retention or anterograde trafficking of proteins at the ER--Golgi or protein cycling within the endosomal/lysosomal system ([@bib48]; [@bib29]). Recent studies have extended our knowledge of the functional effects of palmitoylation on protein sorting by highlighting novel roles for this modification in targeting to cilia and flagella ([@bib18]; [@bib9]; [@bib21]) and to the cleavage furrow of dividing cells ([@bib32]).

What is the underlying mechanistic basis for the effects of palmitoylation on protein sorting? For some soluble proteins, palmitoylation may be a passive sorting signal, acting only as an essential membrane anchor that allows other domains of the protein to regulate subsequent trafficking. However, palmitoylation also has active effects on protein sorting, achieved by partitioning of proteins into cholesterol-rich membrane subdomains or rafts ([@bib45]), changing protein orientation at the membrane and thus affecting protein--protein interactions ([@bib33]; [@bib47]), regulating the ubiquitination status of proteins and thereby modulating ubiquitination-dependent protein sorting ([@bib87]; [@bib48]; [@bib1]), or affecting the transmembrane orientation of palmitoylated proteins in the membrane bilayer ([@bib1]).

Reversible palmitoylation dynamically regulates protein localization
====================================================================

In contrast to other static lipid modifications, the versatility of palmitoylation as a membrane interaction and protein sorting module is greatly enhanced by its reversibility. It has long been appreciated that the palmitoylation of many (but not all) proteins is dynamic ([@bib51]) and can be modulated in response to cell stimulation ([@bib12]; [@bib59]; [@bib90]). Although palmitoylation dynamics of transmembrane proteins can impact sorting to distinct membrane compartments, depalmitoylation of soluble proteins can also mediate membrane release and cytosolic diffusion. Thus, the rapid palmitoylation and depalmitoylation dynamics of many proteins add an extra level of complexity to the effects of this posttranslational modification on protein sorting.

The effects of palmitoylation--depalmitoylation dynamics have been extensively analyzed for palmitoylated Ras isoforms ([@bib25]; [@bib70]; [@bib74]). Farnesylated H- and N-Ras exhibit a weak membrane affinity that mediates interaction with Golgi membranes. Palmitoylation of Ras at this compartment promotes stable membrane association and trafficking from the Golgi to the plasma membrane. Subsequent depalmitoylation releases Ras from the plasma membrane into the cytosol, and the process of palmitoylation at the Golgi and trafficking to the plasma membrane is repeated ([Fig. 1 B](#fig1){ref-type="fig"}). This palmitoylation cycle achieves a constant flux of Ras proteins from Golgi to plasma membrane and was suggested to prevent spillover of Ras onto other cellular membranes by constantly resetting the intracellular localization ([@bib25]; [@bib70]).

The Ras cycling pathway is an example of how constitutive palmitoylation dynamics coordinate protein sorting. For some proteins, palmitoylation turnover and corresponding changes in intracellular localization can also be regulated by cell activity. Protein palmitoylation dynamics that are subject to regulation have been particularly well characterized for postsynaptic proteins; palmitoylation of the molecular scaffold PSD95 and AMPA and NMDA glutamate receptors are all regulated by synaptic activity ([@bib17]; [@bib33], [@bib34]). PSD95 is a peripheral palmitoylated protein that coordinates protein clustering at postsynaptic sites. This protein was suggested to display a decreased palmitoylation in response to glutamate receptor activation, which corresponded with a reduced synaptic clustering of both PSD95 and AMPA receptors. Palmitoylation of GluR1/GluR2 subunits of AMPA receptors and NR2A/2B subunits of NMDA receptors is also modulated by synaptic activity. The palmitoylation status of GluR1 affects association with the 4.1N protein, regulating activity-dependent receptor internalization and plasma membrane insertion dynamics ([@bib33]; [@bib47]). Dynamic palmitoylation of NR2 subunits also modulates cell surface expression of the NMDA receptor ([@bib34]). Thus, neurons use dynamic palmitoylation as a response mode to couple changes in synaptic activity to changes in protein localization.

Spatiotemporal palmitoylation dynamics
======================================

Classically, palmitoylation dynamics have been studied using radiolabeled palmitate and pulse-chase protocols; for example, this approach indicated a half-life for N-Ras palmitoylation of ∼20 min ([@bib51]) and showed that palmitoylation of Gα subunits of heterotrimeric G proteins can be modulated by agonist stimulation ([@bib12]; [@bib59]; [@bib90]).

Recently, the intracellular dynamics of palmitoylation and palmitoylation-dependent protein trafficking have been investigated using fluorescence imaging. The power of biochemical radiolabeling techniques comes from the ability to selectively follow the fate of a labeled pool of protein by pulse chase. In contrast, conventional confocal microscopy analysis of fluorescent proteins is not well suited to allow older proteins to be distinguished from newly synthesized proteins, static protein localizations to be differentiated from dynamic trafficking, and resolution of palmitoylated and unpalmitoylated proteins. However, these issues can be addressed by synchronizing the protein under investigation or by selective photoactivation/photobleaching of a specific pool of the protein or by using visible membrane accumulation of soluble proteins as an indicator of palmitoylation. These techniques were successfully used in the landmark publications that detailed the palmitoylation-dependent cycling pathway of Ras proteins ([@bib25]; [@bib70]).

Recent studies used microinjection of semisynthetic N-Ras as a means to study real-time spatiotemporal dynamics of palmitoylation and membrane targeting ([@bib70], [@bib71]); microinjection of fluorescent protein allows the analysis of a synchronized (i.e., chemically identical and with the same initial localization) pool of protein. This elegant approach involves coupling chemically synthesized farnesylated peptides encompassing the C-terminal membrane targeting domain of N-Ras to a Cy3-labeled protein consisting of the remainder of N-Ras (amino acids 1--181) via a maleimidocaproyl linker. By using these semisynthetic farnesylated proteins with intact or mutated palmitoylation sites, high-resolution temporal dynamics together with spatial information on cellular palmitoylation and depalmitoylation reactions were open to investigation.

Immediately after microinjection, farnesylated N-Ras displayed a dispersed localization, which is consistent with its presence in the cytosol and transient association with intracellular membranes ([@bib71]). However, a rapid enrichment of the Cy3-labeled construct became apparent at the Golgi region (t/2 ∼14 s) with plasma membrane staining visible at later time points. The simplest interpretation of these observations is that palmitoylation of the farnesylated N-Ras occurs at the Golgi, promoting early accumulation at this compartment, and is followed by anterograde transport to the plasma membrane. This notion agrees well with previous analyses of Ras protein cycling ([@bib25]; [@bib70]). Nevertheless, it should be noted that palmitoylation of the microinjected semisynthetic Ras protein was not directly assayed in this study. Although technically challenging, it will therefore be of major interest in follow-up studies to perform correlative measurements of palmitoylation and intracellular localization of microinjected Ras. In addition, a recently published study reported that palmitoylated Ras proteins traffic from Golgi to recycling endosomes en route to the plasma membrane ([@bib54]). [@bib71] did not report association of microinjected Ras proteins with recycling endosomes, and it will be important to clarify this apparent discrepancy between these studies.

The progressive pattern of localization of microinjected Ras (i.e., dispersed → Golgi → plasma membrane) was also observed for semisynthetic constructs in which the N terminus of N-Ras (1--181) was ligated to either myristoylated peptides derived from Gα~i1~ or Fyn or to the N-terminal 20 amino acids from GAP43, all of which contain palmitoylation sites. This result suggests that palmitoylation of N-Ras at the Golgi is not dependent on farnesylation per se but may instead be a common feature of peripheral palmitoylated proteins with an underlying membrane affinity. Note that GAP43 lacks any other lipid modifications and had the slowest rate of Golgi accumulation (t/2 = 29 s); this protein may bind to membranes before palmitoylation via an intrinsic weak membrane affinity ([@bib27], [@bib28]). It will be particularly interesting in follow-up studies to examine whether microinjected full-length Gα~i1~, Fyn, and GAP43 display identical intracellular localization dynamics to the peptide sequences that were fused to N-Ras. This issue is relevant because previous work has shown that regions distant from palmitoylation sites can have a marked influence on the specificity of interaction with DHHC proteins; for example, the yeast vacuolar protein Vac8 was palmitoylated specifically by Pfa3 in vitro, but the isolated palmitoylation domain from this protein was palmitoylated by all five yeast DHHC proteins that were examined ([@bib60]).

Many other palmitoylated peripheral proteins do not display obvious steady-state localization at the Golgi but instead associate with the plasma membrane and endosomal membranes ([@bib3]; [@bib42]; [@bib75]). The absence of such proteins from the Golgi might indicate that they are not modified by Golgi-localized DHHC proteins or could instead reflect a different rate of palmitate turnover and subsequent Golgi recycling ([Fig. 2](#fig2){ref-type="fig"}). Interestingly, proteins in this category, including Fyn, TC10, R-Ras, RhoB, and Rap2C all displayed colocalization with a Golgi marker when vesicular traffic through the secretory pathway was blocked by low temperature ([@bib71]). This observation implies that after their synthesis, these proteins traffic via the Golgi and is consistent with the notion that the Golgi may be a specialized reaction center for the palmitoylation of all newly synthesized peripheral proteins and for a subset that undergo rapid depalmitoylation dynamics.

![**Regulation of protein localization by palmitoylation dynamics.** The illustration depicts three palmitoylated proteins that have different rates of depalmitoylation. In this context, the term depalmitoylation refers to the complete absence of palmitoyl groups on the protein. Rapid depalmitoylation is associated with an enriched steady-state localization on Golgi membranes. This is achieved by depalmitoylation promoting membrane release and subsequent palmitoylation by Golgi-specific DHHC proteins leading to an accumulation at this compartment. Rapid depalmitoylation prevents excessive accumulation on endosomes via vesicular trafficking from the plasma membrane. In contrast, proteins that have a slower rate of depalmitoylation are maintained on membranes for longer and reach endosomal membranes via the plasma membrane. Note that a slower depalmitoylation rate may be achieved by a relative resistance to thioesterases, and/or the presence of many palmitoylated cysteines, and/or palmitoylation by DHHC proteins beyond the Golgi. All of these situations would limit the amount of the protein in a completely depalmitoylated state. This slower rate of depalmitoylation and membrane release limits the steady-state distribution on Golgi membranes.](JCB_201008160_RGB_Fig2){#fig2}

The Golgi as a hub for palmitoylation of peripheral proteins
============================================================

The suggestion that palmitoylation of newly synthesized peripheral proteins is a Golgi-specific event is largely consistent with previously published data. Although DHHC palmitoyl transferases associate with a range of organelles, including the ER, Golgi, and plasma membrane ([@bib63]; [@bib30]), independent analyses of DHHC substrate pairs have returned a high percentage of Golgi DHHC proteins as positive hits ([@bib22], [@bib23]; [@bib38]; [@bib20]; [@bib27], [@bib30]; [@bib86]). Indeed, DHHC9 displays specificity toward H- and N-Ras ([@bib82]) and is Golgi localized ([@bib82]). However, [@bib71] argued against any rigid requirements for DHHC substrate specificity and reported that DHHC9 knockdown (at the mRNA level at least) did not affect the intracellular localization of H-Ras or recovery kinetics after photobleaching of Golgi-localized H-Ras. To examine more closely whether the palmitoylation domain of N-Ras contained a recognition motif for interaction with specific DHHC proteins, the amino acids around the palmitoylation site were changed to their stereoisomeric (i.e., D-amino acids) counterparts. The insertion of these D-amino acids, which was predicted to disrupt any specific protein-binding site, had no major effect on Golgi accumulation of the microinjected proteins ([@bib71]). Further analysis suggested that there was also not an essential DHHC recognition domain in the remainder of the Ras protein. These observations suggest that the DHHC proteins that modify Ras do not require a specific signature of the palmitoylated domain or upstream region and implies that palmitoylation of peripheral proteins may not be restrained by tight enzyme substrate specificities; the major requirement for palmitoylation presumably being a suitable cysteine in close membrane proximity. However, this idea is not readily consistent with other studies that have highlighted features of both DHHC proteins and substrate proteins that contribute to specificity of interaction ([@bib28], [@bib30]; [@bib39]; [@bib60]) or that identified a requirement for a specific DHHC protein for palmitoylation of a specific substrate ([@bib73]; [@bib64]; [@bib81]; [@bib18]; [@bib39]; [@bib61]; [@bib85]). Indeed, depletion of a single DHHC protein, Erf2, had a marked impact on the palmitoylation of yeast Ras ([@bib6]; [@bib73]). Further work is clearly required to delineate the reasons for these apparent inconsistencies.

If the Golgi really is a super-reaction center for palmitoylation of peripheral proteins in mammalian cells, it will be of great interest to determine how this is achieved. Are Golgi-localized enzymes highly efficient? Are cofactors required for palmitoylation enriched at the Golgi? Do peripheral proteins interact in a slightly different way with Golgi membranes, making them more susceptible to palmitoylation? Most peripheral palmitoylated proteins associate with post-Golgi membranes (particularly the plasma membrane) after palmitoylation. Thus, specific palmitoylation at the Golgi might be an important prerequisite to ensure plasma membrane trafficking. A particular feature of palmitate that might facilitate Golgi to plasma membrane trafficking is its affinity for cholesterol-rich lipid raft domains ([@bib53]; [@bib45]). It was recently proposed that raft domains might act as platforms for vesicle budding from the Golgi ([@bib67]), and thus, palmitoylation-dependent association with these domains would be predicted to promote protein traffic to the plasma membrane. In support of the idea that palmitoylation at the Golgi is important for correct trafficking of peripheral proteins, we recently identified a connection between the palmitoylation of cysteine-string protein (CSP) at the Golgi and its subsequent sorting ([@bib27]). A mutant form of CSP with an enhanced membrane affinity associates with ER membranes and is only palmitoylated when ER and Golgi membranes are mixed by applying brefeldin A ([@bib27]). Interestingly, however, after washout of brefeldin A, the Golgi recovers but the CSP mutant remains trapped at the ER ([@bib27]), perhaps reflecting a disconnect between forward transport of peripheral palmitoylated proteins and the lipid environment of ER membranes (cholesterol poor).

Although the Golgi has been highlighted as a possible hub for palmitoylation of peripheral mammalian proteins, the yeast Ras palmitoyl transferase (Erf2) is localized to the ER ([@bib6]). Thus, there currently appears to be marked differences in the palmitoylation pathways of mammalian and yeast Ras proteins, which might reflect reported differences in the intracellular trafficking itineraries of these proteins ([@bib14]; [@bib89]).

Regulation of spatial patterns of palmitoylation by initial membrane interaction
================================================================================

A key aspect of membrane targeting and cycling of dually lipidated proteins such as H/N-Ras, and the compartment where palmitoylation occurs, is the membrane interaction dynamics of the monofarnesylated protein. It is often implied that peripheral proteins bind to all or any intracellular membrane before palmitoylation; but is this the case? Does farnesylated Ras have an equal affinity for all intracellular membranes and, therefore, an unbiased membrane sampling before palmitoylation? In vitro experiments suggest that this may not be the case, as membrane interactions of farnesylated peptides are affected by membrane lipid composition ([@bib24]). Binding of farnesylated N-Ras to liquid-ordered membranes containing saturated phospholipids and cholesterol was reduced compared with liquid-disordered membranes made from an unsaturated phospholipid. These findings are particularly relevant given the high concentration of cholesterol in the plasma and endosomal membranes compared with membranes such as the ER ([@bib58]). Semisynthetic proteins containing a single farnesyl or myristoyl group were suggested to interact with the plasma membrane based on total internal fluorescence microscopy analysis ([@bib71]); however, there was no indication of whether this interaction occurred with the same efficiency as interaction with ER--Golgi membranes. Visual inspection of the localization of farnesylated Ras proteins and peptides expressed in cells via plasmid transfection reveals clear ER and Golgi staining, whereas interaction with other membrane compartments (including the plasma membrane) is less obvious ([@bib11]; [@bib70], [@bib71]). Therefore, peripheral proteins may display a preference for interaction with specific membrane compartments rather than binding randomly to any intracellular membrane. This would clearly provide palmitoylation-dependent protein cycling with more specificity and directionality. The precise membrane interaction dynamics of peripheral proteins before palmitoylation therefore merits further high-resolution analysis.

Palmitoylation reactions beyond the Golgi
=========================================

Although the Golgi appears to function as a hub for palmitoylation of newly synthesized and cycling peripheral proteins, certain proteins undergo dynamic palmitoylation remodeling without accessing the Golgi. This suggests that active DHHC proteins are localized in post-Golgi compartments. Indeed, DHHC2 and DHHC5 associate with the plasma membrane in neuroendocrine cells ([@bib30]), and these proteins are present on post-Golgi membranes in neuronal dendrites and at the postsynaptic density ([@bib61]; [@bib46]). SNAP25, a multiply palmitoylated peripheral protein, is modified by Golgi-localized DHHC proteins ([@bib22], [@bib23]; [@bib38]; [@bib28], [@bib30]), which promote stable membrane attachment of SNAP25 ([@bib28]). Recent work also reported that SNAP25 can be palmitoylated by DHHC2 but that this enzyme is unable to promote stable membrane attachment ([@bib30]). This observation is consistent with the idea that palmitoylation of newly synthesized SNAP25 (which promotes membrane association) is restricted to the Golgi and that modification by post-Golgi DHHCs is only relevant once SNAP25 has been trafficked from Golgi to plasma membrane. This may reflect a weaker association between SNAP25 and DHHC2, such that productive interaction can only occur when SNAP25 is stably membrane associated. However, it is also consistent with the idea that unpalmitoylated SNAP25 may have a higher affinity for Golgi membranes than the plasma membrane, again reinforcing the importance of membrane affinities and preferences of peripheral proteins before palmitoylation (see previous paragraph).

In hippocampal neurons, DHHC2 is associated with mobile dendritic vesicles of unknown origin, and total internal reflection microscopy suggested that inhibition of synaptic activity promotes an increase in DHHC2 levels either at or just beneath the plasma membrane ([@bib61]). Interestingly, this movement of DHHC2 correlates with enhanced palmitoylation and synaptic clustering of PSD95 ([@bib17]; [@bib61]), and depletion of DHHC2 was reported to inhibit the increase in synaptic clustering of PSD95 after synaptic blockade. This work illustrates that dynamic palmitoylation can be achieved without peripheral proteins (such as PSD95) visiting the Golgi. It is interesting to note that depletion of DHHC3, which is localized to the somatic Golgi, also inhibited synaptic accumulation of PSD95. However, in contrast with DHHC2 depletion, knockdown of DHHC3 had no effect on the activity-dependent increase in synaptic clustering of PSD95 ([@bib61]). This suggests that Golgi-localized DHHC3 is involved in the initial palmitoylation of newly synthesized PSD95, before dendritic targeting.

CSP, an important neuroprotective DnaJ chaperone, is palmitoylated by Golgi-localized DHHC enzymes (DHHC3, DHHC7, DHHC15, and DHHC17; [@bib27]). In this regard, CSP is similar to most other peripheral palmitoylated proteins. Consistent with the analyses of CSP palmitoylation in mammalian cells, disruption of DHHC17 in *Drosophila melanogaster* resulted in a loss of palmitoylation and mislocalization of CSP ([@bib64]; [@bib81]). Surprisingly, however, DHHC17 does not exhibit a Golgi localization in *Drosophila* neurons but, instead, has a presynaptic distribution on synaptic vesicles or at the presynaptic plasma membrane ([@bib64]; [@bib81]). Although palmitoylation cycles have not been reported for CSP, it is possible that DHHC17 is important for regulating local palmitoylation dynamics of CSP in *Drosophila* presynaptic terminals.

Finally, there is also strong evidence to show that peripheral membrane proteins can undergo palmitoylation beyond the confines of the Golgi in yeast cells. As discussed earlier, Ras is modified by ER-localized ERF2 ([@bib6]), and palmitoylation and membrane association of the yeast vacuolar fusion protein Vac8 are also markedly reduced after depletion of the DHHC protein Pfa3, which is localized to the vacuole membrane ([@bib37]; [@bib79]).

Mechanisms and spatiotemporal dynamics of depalmitoylation
==========================================================

In contrast to the wealth of information available on palmitoylating enzymes, our understanding of the proteins that regulate protein depalmitoylation is poor. Two main candidate thioesterases have been identified. Protein palmitoyl thioesterase 1 (Ppt1) depalmitoylates H-Ras and different Gα subunits in vitro ([@bib8]). Although there are reports that a cytosolic pool of Ppt1 may be present in cells ([@bib44]), this protein is thought to be predominantly localized to the lysosomal lumen ([@bib35]), where it is believed to function in depalmitoylation reactions occurring during protein degradation. Acyl protein thioesterase 1 (Apt1) reportedly displays thioesterase activity toward G~i~α~1~, H-Ras, eNOS, and certain viral proteins ([@bib16]; [@bib93]; [@bib88]) but is inactive against other proteins such as caveolin ([@bib93]; [@bib88]). Importantly, Apt1 has a cytosolic localization, suggesting that it can regulate cellular palmitoylation dynamics. In support of this idea, overexpression of Apt1 into HEK293 cells was reported to increase the rate of removal of radiolabeled palmitate from G~s~α in pulse-chase experiments ([@bib16]).

Despite Apt1 being identified many years ago, the physiological importance of this protein as a thioesterase is not clear. However, a recent study reported an important function for Apt1 in controlling dendritic spine volume, possibly by regulating palmitoylation and membrane localization of Gα~13~ ([@bib78]). The recent description of a novel Apt1 inhibitor (palmostatin B) should provide an important tool to more finely dissect the function of this protein in cellular palmitoylation dynamics ([@bib13]). Initial analysis with palmostatin B suggests that it promotes a moderate increase in Ras palmitoylation and disrupts the intracellular localization of this protein.

Although our understanding of the mechanisms of depalmitoylation is limited, the spatiotemporal dynamics of this process were investigated by microinjection of semisynthetic N-Ras containing both farnesyl and palmitoyl chains ([@bib71]). Previous analysis of an N-Ras protein in which the palmitoyl group was attached by a noncleavable thioether linkage revealed a dispersed intracellular localization without Golgi enrichment ([@bib70]). This localization was suggested to reflect a requirement for active palmitoylation/depalmitoylation cycling to achieve the correct localization of Ras. The palmitoylated protein with a cleavable thioester bond was therefore not expected to display any initial membrane-targeting specificity. Despite this, the construct rapidly accumulated at the Golgi (t/2 = 27 s). This Golgi accumulation was suggested to follow on from binding of the farnesylated/palmitoylated protein to any membrane, depalmitoylation, cytosolic diffusion, and subsequent repalmitoylation at the Golgi. There were two main interpretations made from this behavior of farnesylated and palmitoylated N-Ras: (1) depalmitoylation must be very rapid to account for the speed of Golgi accumulation and (2) depalmitoylation must occur throughout the cell because if it was confined to a specific location, association of the farnesylated and palmitoylated protein with some membranes would be irreversible.

If depalmitoylation is not restricted to a specific membrane compartment, this suggests (a) a common depalmitoylase with access to many membranes (consistent with the cytosolic localization of Apt1), (b) a group of depalmitoylating enzymes with wide membrane compartment coverage, or (c) nonenzymatic depalmitoylation.

The same spatiotemporal pattern of localization was observed for a farnesylated/palmitoylated protein containing D-amino acids at the palmitoylation site ([@bib71]), suggesting that depalmitoylation does not require a specific recognition sequence around this region. How would a cytosolic thioesterase like Apt1 recognize membrane-embedded thioester linkages without the presence of a defined consensus sequence? It is clear that much more research on Apt1 is required and that the identity of novel inhibitors will greatly facilitate this. One interesting angle is to determine whether the turnover of palmitate on cellular proteins correlates with the ability of Apt1 to promote depalmitoylation in vitro. For example, caveolin is not a substrate of Apt1 in vitro and does not undergo rapid dynamic palmitoylation in cells ([@bib65]), and the reverse is obviously true for proteins such as eNOS and Ras.

Interplay between palmitoylation and other posttranslational modifications
==========================================================================

DHHC proteins are clearly master regulators of intracellular palmitoylation reactions, and thioesterases (such as Apt1) may be equally important. However, are these enzymes the only means of regulating palmitoylation? In fact, there is evidence that palmitoylation/depalmitoylation dynamics can also be modulated by distinct posttranslational modifications present on the target protein.

Interplay between palmitoylation and phosphorylation was recognized many years ago for the β~2~-adrenergic G protein--coupled receptor ([@bib56]). Mutation of the palmitoylated cysteine in the C-terminal tail of this receptor led to an increased level of basal phosphorylation and a loss of coupling to Gs ([@bib62]; [@bib56]). The effects of mutating the palmitoylation site were not caused by a loss of palmitoylation per se but rather by the increased phosphorylation of the palmitoylation-deficient mutant ([@bib57]). Palmitoylation--phosphorylation interplay has also been reported to regulate trafficking of AMPA and NMDA receptor subunits ([@bib34]; [@bib47]). For GluR1 subunits of AMPA receptors, depalmitoylation was suggested to enable the more-efficient phosphorylation of neighboring serine residues. This phosphorylation in turn increased the interaction of GluR1 with 4.1N protein, which modulated plasma membrane internalization and insertion dynamics of AMPA receptors ([@bib47]). How does palmitoylation regulate phosphorylation? One potential mechanism is membrane insertion of palmitoylated cysteines restricting access of protein kinases to the adjacent phosphorylation sites ([Fig. 3 A](#fig3){ref-type="fig"}).

![**Interplay between phosphorylation/nitrosylation and palmitoylation.** (A) Reciprocal regulation of transmembrane proteins. (1) Negatively charged phosphate group prevents palmitoylation of an adjacent cysteine by blocking membrane interaction. (2) Palmitoylation-mediated membrane association prevents access of protein kinases to an adjacent phosphorylation site. (3) Phosphorylation could alter the depalmitoylation rate of a neighboring cysteine, e.g., by increasing access to a thioesterase enzyme. (B) Phosphorylation of a soluble protein prevents palmitoylation by inhibiting transient membrane interaction. (C, 1) Possible regulatory effects of nitrosylation on palmitoylation. Nitrosylation may prevent palmitoylation by direct competition for cysteine residues. (2) It is also possible that nitrosylation could directly displace palmitate. Note that the examples shown do not illustrate the full range of effects that phosphorylation might have on palmitoylation and vice versa.](JCB_201008160_RGB_Fig3){#fig3}

If palmitoylation can regulate phosphorylation, can phosphorylation regulate palmitoylation? The STREX variant of BK potassium channels contains a PKA phosphorylation site within the cytoplasmic C-terminal tail that mediates channel inhibition ([@bib83]). A recent study reported that the STREX variant also contains palmitoylated cysteines adjacent to the PKA site that regulate plasma membrane binding of the cytosolic C terminus ([@bib84]). Introduction of a phosphomimetic mutation at the PKA phosphorylation site or activation of cellular PKA perturbed palmitoylation-dependent membrane association of the C-terminal tail of STREX. Importantly, the full-length channel lacking the palmitoylated cysteines in the STREX domain was no longer subject to PKA-mediated inhibition, implying that phospho-regulation of the STREX channel is achieved via changes in palmitoylation and membrane association of the cytoplasmic C terminus.

Phosphorylation also appears to regulate palmitoylation of the cyclic nucleotide phosphodiesterase (PDE) isoform PDE10A2 ([@bib10]). The N terminus of PDE10A2 contains a palmitoylated cysteine residue (Cys11) that is essential for membrane anchoring and efficient dendritic transport in striatal neurons. Palmitoylation was perturbed when phosphomimetic mutations were introduced into a downstream PKA phosphorylation site (Thr-16). Does phosphorylation at Thr-16 actively promote depalmitoylation of Cys-11, or does it block palmitoylation of this cysteine? In fact, PKA activation markedly enhanced PDE10A2 phosphorylation but had no acute effect on membrane expression levels. This observation suggests that phosphorylation does not promote depalmitoylation and membrane release of PDE10A2 but, instead, likely inhibits membrane binding by blocking palmitoylation. This phospho-regulation of palmitoylation might be relevant to many palmitoylated peripheral proteins and could represent a mechanism to promote a shift toward the depalmitoylated state of a protein in the absence of active (thioesterase driven) depalmitoylation. Negatively charged phosphate groups are likely to inhibit palmitoylation of neighboring cysteines by interfering with membrane interactions before palmitoylation ([Fig. 3](#fig3){ref-type="fig"}).

Another posttranslational modification that may impact palmitoylation dynamics is nitrosylation. Nitric oxide (NO) is produced from [l]{.smallcaps}-arginine by NO synthase enzymes (NOS) and can directly modify cysteines by S-nitrosylation ([@bib80]); this modification might therefore regulate palmitoylation dynamics by direct competition. The NO donor SIN-1 inhibited the basal level and the isoproterenol-stimulated increase in palmitate incorporation into β2 adrenergic receptor ([@bib2]). Palmitate incorporation into H-Ras, caveolin, SNAP25, and certain viral proteins has also been reported to be modified by NO donors ([@bib36]; [@bib5]; [@bib4]). Indeed, the NO donor S-nitrosocysteine accelerated removal of radiolabeled palmitate from H-Ras in pulse-chase experiments ([@bib5]), raising the intriguing possibility that NO may directly displace palmitate from modified proteins ([Fig. 3 C](#fig3){ref-type="fig"}).

Overall, there is sufficient published data to suggest that NO may be an important regulator of palmitoylation dynamics. The development of more sensitive techniques to directly study nitrosylation is required to more rigorously delineate interplay between this modification and palmitoylation. It will be particularly important in future studies to determine how palmitoylation dynamics are affected by endogenously produced NO. The intracellular diffusion range of NO from its site of production is limited, and thus, interplay between palmitoylation and nitrosylation will be more physiologically relevant for palmitoylated proteins that interact either directly or indirectly with NOS enzymes.

Perspective
===========

Landmark studies in yeast highlighted the DHHC protein family as the catalysts of intracellular membrane fusion reactions and provided an essential spark to the palmitoylation field. This, together with the continuing development of new methodologies and reagents, has served as a platform for rapid expansion in our understanding of the mechanisms, spatiotemporal dynamics, and outcomes of protein palmitoylation. Techniques such as acyl-biotin exchange and click chemistry have offered highly sensitive alternatives to radiolabeling for the study of cellular palmitoylation ([@bib15]; [@bib52]; [@bib92]). These approaches also permit the palmitoylation status of proteins to be studied in situ without cell labeling (acyl-biotin exchange) or the analysis of spatial patterns of palmitoylated proteins by fluorescence imaging ([@bib32]). Furthermore, both techniques have facilitated analysis of the cellular palmitoylome in both yeast and mammalian cells ([@bib73]; [@bib41]; [@bib52]). The recent development of Apt1 inhibitors is an important step toward further delineating the function of this protein and developing an enhanced understanding of cellular depalmitoylation dynamics ([@bib13]). It is expected that further technological developments will maintain the rapid pace of palmitoylation research. In particular, the development of more specific and selective inhibitors against the DHHC protein family ([@bib69]) will be a key to delineating the individual functions of these proteins and their contribution to the spatiotemporal dynamics of cellular palmitoylation reactions.
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